[1]
“Formulation and evaluation of in-situ gel for otic administration of Rivastigmine for the treatment of Alzheimerś Disease”, VER, vol. 8, no. 15s, pp. 24–33, Nov. 2025, Accessed: Dec. 26, 2025. [Online]. Available: https://verjournal.com/index.php/ver/article/view/1113